Ancient DNA has been pulled from a permafrost-preserved woolly mammoth found in Siberia, and scientists are thrilled. They ...

Molecular mechanism uncovered in mice by UC Santa Cruz researchers reveals how a father’s diet, stress, and other ...

Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

Oxford Nanopore Technologies (LON:ONT) outlined progress in expanding its nanopore-based sequencing platform and highlighted ...

Researchers at University of California San Diego have identified a previously unrecognized treatment target for ...

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform ...

Freenome today announced an initiative to advance its blood-based early cancer screening program by leveraging NVIDIA deep learning technology and expertise to improve the recognition of ...

The first line of treatment for cancer is, whenever possible, to remove the cancerous tissue from the body. Though often ...

This innovative company's stock price marched higher today in the FTSE 250 index. Might this be my first Stocks and Shares ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Oxford Nanopore Technologies today announces that the GridIONtm Dx is now both CE and UKCA marked, making it the company's ...